B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SMAD2

MOLECULAR TARGET

SMAD family member 2

UniProt: Q15796NCBI Gene: 408749 compounds

SMAD2 (SMAD family member 2) is targeted by 49 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SMAD2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1cycloheximide1.393
2Disulfiram1.393
3Apigenin 5,7,4'-trihydroxy-flavone,1.102
4Kaempferols1.102
5Quercetin1.102
6Azacitidine1.102
7Azacitidine1.102
8Colchicine1.102
9Dactinomycin1.102
10Danazol1.102
11Ethidium1.102
12Flutamide1.102
13Loratadine1.102
14Nisoldipine1.102
15Podophyllotoxin1.102
16vinblastine sulfate1.102
17chrysin0.691
18egcg0.691
19Fluoxetine0.691
20Tannins Polyphenolic compounds with molecular weights of around 500-3000 daltons and containing enough hydroxyl groups (1-2 per 100 MW) for effective cross linking of other compounds (ASTRINGENTS).0.691
21Astemizole Antihistamine drug now withdrawn from0.691
22Bortezomib0.691
23Celecoxib0.691
24Ciclopirox0.691
25Cladribine0.691
26Dasatinib0.691
27Daunorubicin0.691
28Dinitrochlorobenzene0.691
29Domperidone0.691
30Emetine0.691
31Equilin0.691
32Ethinyl Estradiol0.691
33Ezetimibe0.691
34Idazoxan0.691
35Lynestrenol0.691
36Nocodazole Nocodazole is0.691
37Masoprocol0.691
38o-Phthalaldehyde0.691
39Oxyphenbutazone0.691
40Perphenazine0.691
41pivampicillin0.691
42Promethazine0.691
43Rotenone0.691
44Salmeterol Xinafoate0.691
45Sulbactam0.691
46trequinsin hydrochloride0.691
47triflupromazine hydrochloride0.691
48Vincristine0.691
49Zearalenone (S-(E))-3,4,5,6,8,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradec in-1,7(8H)-dione.0.691

About SMAD2 as a Drug Target

SMAD2 (SMAD family member 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 49 compounds with documented SMAD2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SMAD2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.